Pharmabiz2h
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...
Pharmabiz20h
Aakash Healthcare in association with ANVKA Foundation launches nationwide initiative to transform lives of children with bone deformities
Our Bureau, Mumbai Wednesday, March 12, 2025, 16:45 Hrs [IST] ...
Pharmabiz2h
Biogen begins TRANSCEND phase 3 study of felzartamab to treat late antibody-mediated rejection in kidney transplant patients
Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...
Pharmabiz5h
DGFT seeks industry feedback on proposed amendments to "stock and sale" export authorization for SCOMET items
DGFT seeks industry feedback on proposed amendments to "stock and sale" export authorization for SCOMET items: Shardul Nautiyal, Mumbai Thursday, March 13, 2025, 08:00 Hrs [IST] T ...
Pharmabiz5h
ICMR boosts aviation medicine with its new Centre for Advanced Research on Space Psychology
ICMR boosts aviation medicine with its new Centre for Advanced Research on Space Psychology: Nandita Vijayasimha Bengaluru Thursday, March 13, 2025, 08:00 Hrs [IST] The Indian Cou ...
Pharmabiz5h
Panel raises concern over regulatory roadblocks affecting medical devices sector
Panel raises concern over regulatory roadblocks affecting medical devices sector: Gireesh Babu, New Delhi Thursday, March 13, 2025, 08:00 Hrs [IST] The delays and lack of transpar ...
Pharmabiz5h
Counterfeit drugs reach market due to grey marketing companies’ involvement: Bihar DC
Counterfeit drugs reach market due to grey marketing companies’ involvement: Bihar DC: Peethaambaran Kunnathoor, Chennai Thursday, March 13, 2025, 08:00 Hrs [IST] The present co ...
Pharmabiz5h
Adapt risk-based approach in export approvals, says expert
Our Bureau, New Delhi Thursday, March 13, 2025, 08:00 Hrs [IST] The drug regulators may look at adapting a risk-based a ...
Pharmabiz22h
Caristo Diagnostics’ CaRi-Plaque technology, an AI-assisted image analysis application to aid the diagnosis of CAD receives US FDA 510(k) clearance
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
Pharmabiz19h
Hudson Therapeutics announces Shaperon to initiate phase 2b part 2 clinical trial of a topically administered drug, NuGel
Cambridge, Massachusetts Wednesday, March 12, 2025, 18:00 Hrs [IST] ...
Pharmabiz20h
Alkem Labs launches generic empagliflozin and its combinations in India under the brand name “Empanorm”
Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...
Pharmabiz21h
Boehringer Ingelheim partners with Veeva to launch ‘One Medicine Platform’
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, and Veeva Systems, global leader in cloud software for the life sciences industry, have announced the launch ...